The Role of Wharton’s Jelly Mesenchymal Stem Cells in Diabetes Mellitus

Diabetes mellitus is one of the most common chronic disorders in the world, which characterized by progressive destruction of insulin-producing beta cells in the pancreatic islets of Langerhans. Currently, great interest has been generated in human umbilical cord mesenchymal stem cells (huMSCs), which are potential applications for the treatment of diabetes mellitus. Therefore, the aim of this study is that WJMSCs will be induced to differentiate into pancreatic beta-like cells in vitro. At this stage, we isolated and induced cultured huMSCs from the UC’s WJ under specific culture conditions, and then the morphology of huMSCs were monitored under an inverted phase contrast microscope. We envision that these results will provide a basis for the potential use of Wharton’s Jelly MSCs as a source in stem cell-based therapy for diabetes mellitus.

[1]  J. Chai,et al.  The Role of Wharton’s Jelly Mesenchymal Stem Cells in Skin Reconstruction , 2015 .

[2]  E. Michalopoulos,et al.  Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank , 2014, Transfusion.

[3]  G. Chrousos,et al.  Pancreatic Islet Cell Transplantation: An Update , 2013, Annals of Biomedical Engineering.

[4]  M. Conconi,et al.  Phenotype and Differentiation Potential of Stromal Populations Obtained from Various Zones of Human Umbilical Cord: An Overview , 2011 .

[5]  M. Foss,et al.  Stem cell therapy for diabetes mellitus , 2011, Kidney international supplements.

[6]  Tian-hua Huang,et al.  Human umbilical cord mesenchymal stem cells derived from Wharton's jelly differentiate into insulin-producing cells in vitro. , 2011, Chinese medical journal.

[7]  S. Matsumoto Islet cell transplantation for Type 1 diabetes , 2010, Journal of diabetes.

[8]  C. di Ilio,et al.  Proteome analysis of human Wharton's jelly cells during in vitro expansion , 2010, Proteome Science.

[9]  M. Côrrea-Giannella,et al.  Pancreatic islet transplantation , 2009, Diabetology & metabolic syndrome.

[10]  G. Warnock,et al.  Adult stem or progenitor cells in treatment for type 1 diabetes: current progress. , 2007, Canadian journal of surgery. Journal canadien de chirurgie.

[11]  Q. Xie,et al.  Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells. , 2005, Chinese medical journal.

[12]  H. Kolb,et al.  An immune origin of type 2 diabetes? , 2005, Diabetologia.

[13]  Ames,et al.  Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .